Cita APA

Díaz García, C., Serrano Villar, S., García Ruiz de Morales, A. G., Güerri Fernández, R., Pérez Somarriba, J., Sánchez Palomino, S., . . . al., e. (2025). Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/ Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment.

Citación estilo Chicago

Díaz García, Claudio, et al. Two or Three? Clinical and Proteomic Perspectives On Dolutegravir/Lamivudine Versus Bictegravir/ Emtricitabine/Tenofovir Alafenamide As Initial HIV Treatment. 2025.

Cita MLA

Díaz García, Claudio, et al. Two or Three? Clinical and Proteomic Perspectives On Dolutegravir/Lamivudine Versus Bictegravir/ Emtricitabine/Tenofovir Alafenamide As Initial HIV Treatment. 2025.